Khiron Life Sciences acquires Dayacann
On Jan. 21, 2019, Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQB: KHRNF) (Frankfurt: A2JMZC) announced that it had closed the previously announced MOU with Dayacann, holder of Chile's first and only medical cannabis cultivation license.
Dayacann is a joint venture entity established by Fundacion Daya and its Australian partner AusCann Group Holdings Ltd.